About Bonti
Bonti is a company based in Newport Beach (United States) founded in 2015 by Susan Abushakra and Mike Jarpe was acquired by Allergan in September 2018.. Bonti has raised $36.05 million across 5 funding rounds from investors including SVB, Allergan and City Hill. Bonti operates in a competitive market with competitors including Flexion Therapeutics, Eliem Therapeutics, Zogenix, Heron Therapeutics and Egalet, among others.
- Headquarter Newport Beach, United States
- Founders Susan Abushakra, Mike Jarpe
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bonti
Bonti has successfully raised a total of $36.05M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $15.5 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $15.5M
-
First Round
First Round
(15 Sep 2015)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series C - Bonti | Valuation | City Hill |
|
| Jun, 2017 | Amount | Series B - Bonti | Valuation | Viva Ventures Biotech Fund |
|
| Apr, 2017 | Amount | Series B - Bonti | Valuation | RBV Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bonti
Bonti has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Allergan and City Hill. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm and foundation focused on biotech, cleantech, and media & entertainment, education, and more
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
A life sciences venture capital fund is managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bonti
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bonti
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bonti Comparisons
Competitors of Bonti
Bonti operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Eliem Therapeutics, Zogenix, Heron Therapeutics and Egalet, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for pain management are developed with abuse-deterrent designs.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bonti
Frequently Asked Questions about Bonti
When was Bonti founded?
Bonti was founded in 2015.
Where is Bonti located?
Bonti is headquartered in Newport Beach, United States. It is registered at Newport Beach, California, United States.
Is Bonti a funded company?
Bonti is a funded company, having raised a total of $36.05M across 5 funding rounds to date. The company's 1st funding round was a Series B of $11.71M, raised on Sep 15, 2015.
What does Bonti do?
Bonti was founded in 2015 in Newport Beach, United States, as a clinical-stage biotechnology firm. Botulinum neurotoxins are developed using a proprietary platform for therapeutic and aesthetic uses. The lead candidate, EB-001, a serotype E botulinum neurotoxin, is advanced for post-surgical and non-surgical musculoskeletal pain. Muscle hyperactivity, identified as a primary pain driver, is addressed through this approach in ongoing clinical efforts.
Who are the top competitors of Bonti?
Bonti's top competitors include Flexion Therapeutics, Cara Therapeutics and Satsuma Pharmaceuticals.
Who are Bonti's investors?
Bonti has 8 investors. Key investors include SVB, Allergan, City Hill, Viva Ventures Biotech Fund, and RBV Capital.